Publications
2021
- Nishio Ayre, W.et al. 2021. Alternative radiopacifiers for polymethyl methacrylate bone cements: Silane-treated anatase titanium dioxide and yttria-stabilised zirconium dioxide. Journal of Biomaterials Applications 35(10), pp. 1235-1252. (10.1177/0885328220983797)
2016
- Holt, C. A.et al. 2016. Biological changes in tibial subchondral bone following high tibial osteotomy. Osteoarthritis and Cartilage 24(S1), pp. S511-S511. (10.1016/j.joca.2016.01.935)
2015
- Ishtiaq, S.et al. 2015. The effect of nitrogen containing bisphosphonates, zoledronate and alendronate, on the production of pro-angiogenic factors by osteoblastic cells. Cytokine 71(2), pp. 154-160. (10.1016/j.cyto.2014.10.025)
2009
- Henney, N. C.et al. 2009. A large-conductance (BK) potassium channel subtype affects both growth and mineralization of human osteoblasts. American Journal of Physiology - Cell Physiology 297(6), pp. C1397-C1408. (10.1152/ajpcell.00311.2009)
- Williams, A. S.et al. 2009. A functional role for death receptor-3 in arthritis [Abstract]. Cytokine 48(1-2), pp. 134-134. (10.1016/j.cyto.2009.07.568)
- Williams, A. S.et al. 2009. Functional role of dr3 in inflammatory arthritis: A novel target for therapy? [Abstract]. Rheumatology 48(s1), pp. I8-I8. (10.1093/rheumatology/kep704)
- Stevenson, A. E.et al. 2009. Does adiposity status influence femoral cortical strength in rodent models of growth hormone deficiency?. American Journal of Physiology - Endocrinology and Metabolism 296(1), pp. E147-E156. (10.1152/ajpendo.90689.2008)
2008
- Williams, A. S.et al. 2008. The role of death receptor 3 in inflammatory arthritis [Abstract]. Immunology 125, pp. 34-34. (10.1111/j.1365-2567.2008.02974.x)
- Bull, M. J.et al. 2008. The Death Receptor 3-TNF-like protein 1A pathway drives adverse bone pathology in inflammatory arthritis. Journal of Experimental Medicine 205(11), pp. 2457-2464. (10.1084/jem.20072378)
- Janus, D.et al. 2008. Age-dependent effects of growth hormone (GH) on human osteoclasts in growth hormone deficient patients [Abstract]. Hormone Research 70(S1), pp. 80-80. (10.1159/000157528)
- Janus, D.et al. 2008. The effects of recombinant human growth hormone (GH) and insulin-like growth factor-I (IGF-I) on human osteoclasts [Abstract]. Hormone Research 70(S1), pp. 80-80. (10.1159/000157528)
- Gharibi, B.et al. 2008. Evidence for adenosine receptor regulation of osteogenesis versus adipogenesis in mesenchymal stem cells [Abstract]. Calcified Tissue International 83(1), pp. 9-10. (10.1007/s00223-008-9151-4)
- Janus, D.et al. 2008. The effects of recombinant human growth hormone (rhGh) and insulin-like growth FACTOR-I (rhIGF-I) on human osteoclasts [Abstract]. Calcified Tissue International 83(1), pp. 31-32. (10.1007/s00223-008-9151-4)
2007
- Mansergh, F. C.et al. 2007. Osteopenia in Sparc (osteonectin) deficient mice: characterization of phenotypic determinants of femoral strength and changes in gene expression. Physiological genomics 32(1), pp. 64-73. (10.1152/physiolgenomics.00151.2007)
- Davies, J. S.et al. 2007. Adiposity profile in the dwarf (dw/dw) rat: an unusually lean model of profound growth hormone deficiency. American Journal of Physiology - Endocrinology and Metabolism 292(5), pp. E1483-E1494. (10.1152/ajpendo.00417.2006)
2006
- Evans, B. A. J.et al. 2006. Human osteoblast precursors produce extracellular adenosine, which modulates their secretion of IL-6 and osteoprotegerin. Journal of Bone and Mineral Research 21(2), pp. 228-36. (10.1359/JBMR.051021)
2005
- Yee, S. W.et al. 2005. Novel tetralone-derived retinoic acid metabolism blocking agents: synthesis and in vitro evaluation with liver microsomal and MCF-7 CYP26A1 cell assays. Journal of Medicinal Chemistry 48(23), pp. 7123-7131. (10.1021/jm0501681)
2003
- Evans, B. A. J.et al. 2003. Morphological determinants of femoral strength in growth hormone-deficient transgenic growth-retarded (Tgr) rats. Journal of Bone and Mineral Research 18(7), pp. 1308-1316. (10.1359/jbmr.2003.18.7.1308)
2002
- Perez, N. A.et al. 2002. Effects of leptin on number and apoptosis of osteoblasts, and control of leptin production by glucocorticoids. Journal of Bone and Mineral Research 17(7), pp. 1327-1327.
- Davies, J. H.et al. 2002. Chemotherapy-induced apoptosis in human osteoblast-like cells and modulation of their effects by dexamethasone. Journal of Bone and Mineral Research 17(7), pp. 1342-1342.
- Evans, B. A. J.et al. 2002. 3D micro-computed tomography (micro-CT) of trabecular bone from growth hormone deficient transgenic rats. Journal of Bone and Mineral Research 17(7), pp. 1332-1332.
2000
- Warner, J. T.et al. 2000. Undermineralisation and reduced bone strength in growth hormone (GH) deficient transgenic (Tgr) rats. Journal of Bone and Mineral Research (JBMR) 15(6), pp. 1219-1219.